Fortrea To Unveil Q4, Full-Year 2025 Results On Feb 26

KUALA LUMPUR, Jan 30 (Bernama) -- Fortrea, a global contract research organisation (CRO), announced that it will release its fourth quarter (Q4) and full year 2025 financial results on Feb 26, before the market opens.

In a statement, Fortrea said it will also host a conference call on the same day to review the results and conduct a question-and-answer session. Participants can register for the earnings call via the company’s investor relations website.

A replay of the live conference call will be available after the conclusion of the event and accessible in the events and presentations section of the Fortrea Investor Relations website.

Fortrea partners with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life-changing therapies to patients.

The company provides Phase I to IV clinical trial management, clinical pharmacology and consulting services, leveraging more than three decades of experience across over 20 therapeutic areas, with teams operating in about 100 countries.

-- BERNAMA